Key result
Enhanced External Counter Pulsation significantly improved SF-36 general health scores from baseline to 12 months in both nondiabetic (55.1 to 88.1) and diabetic (55.3 to 88.3) coronary heart disease patients.
Why the study?
Does Enhanced External Counter Pulsation improve physical profile and quality of life in diabetic and nondiabetic coronary heart disease patients?
Cohort (n=163)
No
Does Enhanced External Counter Pulsation improve physical profile and quality of life in diabetic and nondiabetic coronary heart disease patients?
p-value: p=<0.0001
EECP is an effective non-invasive therapy that improves physical functional capacity, angina, dyspnea, and overall health-related quality of life in both diabetic and nondiabetic patients with coronary heart disease.
This study was conducted to assess the effect of Enhanced External Counter Pulsation (EECP) on physical profile and Health-Related Quality of Life (HRQoL) in diabetic and nondiabetic Coronary Heart Disease (CHD) patients. This pretest-posttest designed prospective study was conducted among 163 diabetic and nondiabetic coronary heart disease patients in the SAAOL Heart Center, New Delhi. The physical profile of study subjects was assessed through Cooper's 12 minutes' walk test, Canadian Cardiovascular Society (CCS) angina scale and Medical Research Council (MRC) dyspnea scale. The HRQoL of subjects was assessed using SF-36 (short form) and Seattle Angina Questionnaire (SAQ) scale. A significant improvement was observed in blood pressure, heart rate, SpO 2 , VO 2 max, CCS angina and MRC score in both the groups from baseline to 12 months. Significant improvement was also observed in both the scales of HRQoL after EECP treatment at 12 months follow up in all the health domains of SF-36 & SAQ scale with special reference to angina severity and angina stability improvement. In conclusion, EECP is an effective non-invasive therapy to treat diabetic and nondiabetic CHD patients. This non-invasive procedure may improve the physical functional capacity, angina, dyspnea and overall HRQoL of diabetic and nondiabetic CHD patients.
No takes yet. Share an insight, caveat, or question.
A 2018 study conducted a cohort in Coronary Heart Disease with and without Diabetes Mellitus (n=163). Enhanced External Counter Pulsation (EECP) vs. Baseline (pre-treatment) and between diabetic vs nondiabetic groups was evaluated on Health-Related Quality of Life (SF-36 General Health score) at 12 months (p=<0.0001). Enhanced External Counter Pulsation significantly improved SF-36 general health scores from baseline to 12 months in both nondiabetic (55.1 to 88.1) and diabetic (55.3 to 88.3) coronary heart disease patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: